PURPLE BIOTECH LTD-ADR (PPBT) Stock Balance Sheet
NASDAQ:PPBT - Nasdaq - US74638P1093 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.40M | 14.49M | 15.03M | 10.89M | 11.25M | |||
| Marketable Securities | 1.12M | 923.00K | 17.08M | 36.31M | 46.56M | |||
| Receivables | N/A | N/A | N/A | 0.00 | 500.00K | |||
| Other Current Assets | 384.00K | 376.00K | 1.14M | 1.27M | 977.00K | |||
| Total Current Assets | 8.91M | 15.79M | 33.26M | 48.47M | 59.28M | |||
| Non-Current Assets | ||||||||
| PPE Net | 288.00K | 470.00K | 682.00K | 896.00K | 968.00K | |||
| Investments And Advances | N/A | N/A | 0.00 | 347.00K | 3.07M | |||
| Intangibles | 27.84M | 28.04M | 20.68M | 20.48M | 20.48M | |||
| Other Non-Current Assets | N/A | N/A | N/A | 160.00K | 0.00 | |||
| Total Non-Current Assets | 28.13M | 28.51M | 21.37M | 21.73M | 24.52M | |||
| TOTAL ASSETS | 37.04M | 44.30M | 54.62M | 70.20M | 83.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 183.00K | 188.00K | 194.00K | 199.00K | 207.00K | |||
| Accrued Expenses | 126.00K | 2.79M | N/A | 1.97M | 1.65M | |||
| Accounts Payable | 2.53M | 4.21M | 2.13M | 1.49M | 1.24M | |||
| Other Current Liabilities | 1.15M | 0.00 | 4.73M | 593.00K | 0.00 | |||
| Total Current Liabilities | 3.99M | 7.18M | 7.06M | 4.25M | 3.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 163.00K | 321.00K | 550.00K | 688.00K | |||
| Other Non-Current Liabilities | 140.00K | 2.66M | 145.00K | 292.00K | 265.00K | |||
| Total Non-Current Liabilities | 191.00K | 2.91M | 653.00K | 1.12M | 1.32M | |||
| TOTAL LIABILITIES | 4.18M | 10.10M | 7.71M | 5.37M | 4.41M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -114.77M | -99.00M | -79.49M | -59.12M | -39.52M | |||
| Additional Paid In Capital | 147.63M | 133.18M | 126.41M | 123.95M | 118.91M | |||
| Minority Interest | 51.00K | 90.00K | 187.00K | 279.00K | 363.00K | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Other Shareholders' Equity | 0.00 | 19.00K | -6.00K | N/A | N/A | |||
| Shares Outstanding | 2.82M | 1.38M | 1.01M | 970.54K | 938.40K | |||
| Tangible Book Value per Share | 0.01 | 0.02 | 0.14 | 0.25 | 0.34 | |||
| Total Shareholders' Equity | 32.86M | 34.21M | 46.91M | 64.83M | 79.39M | |||
| TOTAL LIABILITIES AND EQUITY | 37.04M | 44.30M | 54.62M | 70.20M | 83.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | 0.01 | 0.01 | 0.01 | |||
| Current Ratio | 2.23 | 2.20 | 4.71 | 11.41 | 19.14 | |||
| Return On Assets (ROA) | -19.55% | -44.87% | -39.67% | -26.19% | -33.41% | |||
| Return On Equity (ROE) | -22.03% | -58.12% | -46.19% | -28.36% | -35.27% | |||
All data in USD , ROIC based on taxRate of 0.21